<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2452">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04433364</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02848 0604</org_study_id>
    <nct_id>NCT04433364</nct_id>
  </id_info>
  <brief_title>COPE - COVID-19 in Pregnancy and Early Childhood</brief_title>
  <acronym>COPE</acronym>
  <official_title>COPE - COVID-19 in Pregnancy and Early Childhood - a Study Protocol for a Prospective Multicentre Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: The emergence of a new coronavirus, coronavirus 2 (SARS-CoV-2) causing a novel
      infection in the human race resulting in a world-spanning pandemic came as a surprise and at
      a tremendous cost both for individual human lives as well as for the society and for the
      health care sector. The knowledge on how this new infection affects both the mother and the
      unborn child as well as the outcomes for the mother and the child in the long run are
      unknown. What is known is based on case-reports and small case-series solely. Both the
      coronaviruses causing Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory
      Syndrome (SARS) can cause a threat to pregnant women and their offspring, which leads to the
      question whether this could be the case also for SARS-CoV-2.

      Aims: To establish a biobank of biological material from infected as well as non-infected
      pregnant women and their offspring. To combine this biobank with Swedish quality and health
      care registers, computerized patient charts and questionnaire data, enabling both short-term
      follow up, such as obstetric outcomes, as well as long-term outcomes both for mother and
      child. To study how the pandemic situation affects both the mother and her partner in their
      experience of pregnancy, childbirth, and early parenthood.

      Design: A national Swedish multicentre study. Women are included when they have a positive
      test for SARS-CoV-2 or a clinical suspicion of coronavirus disease 2019 (COVID-19) (COVID-19
      group). Pregnant women without COVID-19 symptoms will be included at their routine visits
      (Screening group). Blood samples and other biological material will be collected at different
      time-points. Additional predictors and outcomes are collected from the Swedish Pregnancy
      Register as well as obligatory Swedish health registers. The biobank and its linkage to
      health registers through the Swedish personal identification number will enable future
      research. Child development will be followed during the first year of life by questionnaires
      to the parents. Womens' and their partners' experience of childbirth and parenthood will be
      studied in form of questionnaires based on validated instruments as well as in form of
      interviews. Sweden is one of few countries with prerequisites enabling a nearly
      population-based follow-up, even under the pandemic condition with considerable strains for
      the health care system.

      Conclusion: This project will help obstetricians and neonatologists in better recognizing the
      clinical manifestations of the virus, identify possible risk factors during pregnancy and
      tailor therapies along with providing the right level of surveillance and management during
      pregnancy, delivery, and child health care. The project will also enable sharing important
      unusual outcome data with other research collaborators, e.g. outcome for pregnant women with
      diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2, 2020</start_date>
  <completion_date type="Anticipated">June 2, 2041</completion_date>
  <primary_completion_date type="Anticipated">June 2, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Biobank with linkage to registers</measure>
    <time_frame>1-20 years</time_frame>
    <description>establish a biobank and database with bio-samples from both women that are not tested and presumed healthy as well as possibly ill and women confirmed tested positive for SARS-CoV-2 and their infants linked to Swedish health care registers including socio-economic factors and use serological and viral analyses from the biological samples to evaluate maternal, fetal and neonatal outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Experiences of pregnancy during a pandemic</measure>
    <time_frame>1 year</time_frame>
    <description>study how women and their partners experience pregnancy, childbirth and early parenthood in the COVID-19-pandemic, both for women not tested and for women tested positive for SARS-CoV-2.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Sars-CoV2</condition>
  <condition>Covid-19</condition>
  <condition>Pregnancy Complications</condition>
  <condition>Pregnancy Preterm</condition>
  <condition>Pregnancy in Diabetic</condition>
  <condition>Neonatal Infection</condition>
  <arm_group>
    <arm_group_label>Screening group</arm_group_label>
    <description>a general population of women giving birth, called &quot;screening group&quot; included at routine antenatal visits, their partners, and children</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID-19 group</arm_group_label>
    <description>group of women testing positive for SARS-CoV-2 or falling ill with COVID-19, called &quot;COVID-19 group&quot;, their partners, and children</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biological samples, questionnaires and interviews</intervention_name>
    <description>Biological samples: to study impact of testing positive for SARS-CoV-2 during pregnancy samples taken in routine clinical care, samples from already existing research biobanks and the newly established COPE biobank will be used. Time-points: inclusion, at delivery mother and fetus. Covid-19 positive group only: 48-96 h, 2 months postpartum for mother and fetus.
Questionnaires: Women and partners in both groups will fill out electronical questionnaires at different time points during pregnancy and until 12 months postpartum based on validated instruments to test for differences in Self-Efficacy, Anxiety and Depression, Health-related quality of life, Sense of Coherence, PTSD Symptoms, Postpartum Bonding, Childbirth experiences and Self-Efficacy of Breastfeeding. The child's health will be assessed regarding infection until 6 weeks of age and development until 12 months.
Interviews: 24-40 women and partners in both groups. Interviews will be conducted 3 to 6 months after childbirth.</description>
    <arm_group_label>COVID-19 group</arm_group_label>
    <arm_group_label>Screening group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bloodsample from the mother antenatally, at inclusion and at delivery from healthy women, as
      well as NPH-swab and placenta at delivery. Naval cord blood from healthy infants. From
      covid-19 pos women: blood sample antenatally and at diagnosis as well as vaginal, rectal and
      NPH swab and urinary sample. At delivery NPH-swabs as well as vaginal and rectal swabs and
      urinary samples and blood and in case of caesarean section amnion fluid and spinal fluid.
      Breastmilk at 48-96 hours after delivery. From the infant naval cord blood and at 48-96 hours
      after delivery NPH-swab and rectal swab as well as blood sample. For the COVID-19 group a
      follow-up visit during the first year after delivery for bloodsamples of mother and
      child/children.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        18 years of age and above. Attending routine antenatal visits at a participating hospital
        during the study period or are strongly suspicious of or diagnosed with Covid-19 during
        pregnancy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: 18 years of age and above. Attending routine antenatal visits at a
        participating hospital during the study period or are strongly suspicious of or diagnosed
        with Covid-19 during pregnancy.

        For the questionnaire part: language knowledge (translation to several languages planned)
        For the interview part: Swedish language knowledge

        Exclusion Criteria: -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Verena Sengpiel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Verena Sengpiel, MD, PhD</last_name>
    <phone>+46704223475</phone>
    <email>verena.sengpiel@obgyn.gu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ylva Carlsson, MD, PhD</last_name>
    <phone>+46730706546</phone>
    <email>ylva.carlsson@vgregion.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Falu Hospital</name>
      <address>
        <city>Falun</city>
        <state>Dalarna</state>
        <zip>79182</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susanne Hesselman, MD PhD</last_name>
      <phone>+46704939287</phone>
      <email>susanne.hesselman@kbh.uu.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Halmstad lasarett</name>
      <address>
        <city>Halmstad</city>
        <state>Halland</state>
        <zip>30233</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Åsa Ponten, MD PhD</last_name>
      <phone>+46733421310</phone>
      <email>åsa.ponten@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Varbergs sjukhus</name>
      <address>
        <city>Varberg</city>
        <state>Halland</state>
        <zip>43237</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Holmström, MD</last_name>
      <email>sandra.holmstrom@regionhalland.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsingborgs lasarett</name>
      <address>
        <city>Helsingborg</city>
        <state>Skåne</state>
        <zip>25223</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Åsa Leijonhufvud, MD PhD</last_name>
      <email>Asa.Leijonhufvud@skane.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Skåne Universitetssjukhus</name>
      <address>
        <city>Lund</city>
        <state>Skåne</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mehreen Zaigham, MD PhD</last_name>
      <phone>+46760404077</phone>
      <email>mehreen.zaigham@med.lu.se</email>
    </contact>
    <contact_backup>
      <last_name>Ola Andersson, MD PhD</last_name>
      <phone>+46709664180</phone>
      <email>ola.andersson@med.lu.se</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Eskiltuna hospital</name>
      <address>
        <city>Eskilstuna</city>
        <state>Södermanland</state>
        <zip>63003</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ove Axelsson, MD PhD</last_name>
      <phone>+4616103000</phone>
      <email>ove.axelsson@kbh.uu.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boras hospital</name>
      <address>
        <city>Boras</city>
        <state>VGR</state>
        <zip>50182</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pihla Kuusela, MD PhD</last_name>
      <phone>+46336163245</phone>
      <email>Pihla.Kuusela@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Univeristy Hospital</name>
      <address>
        <city>Gothenburg</city>
        <state>VGR</state>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ylva Carlsson, MD PhD</last_name>
      <phone>+46730706546</phone>
      <email>ylva.carlsson@vgregion.se</email>
    </contact>
    <contact_backup>
      <last_name>Elisabeth Salekärr, research nurse</last_name>
      <phone>+46313432483</phone>
      <email>elisabeth.salekarr@vgregion.se</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ryhovs sjukhus</name>
      <address>
        <city>Jönköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Axelsson, MD</last_name>
      <email>danaxl@yahoo.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kalmar Lasarett</name>
      <address>
        <city>Kalmar</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Svenvik, MD</last_name>
      <email>maria.svenvik@regionkalmar.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karlstad lasarett</name>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hugo Hessel, MD</last_name>
      <email>Hugo.Hessel@regionvarmland.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kristiandstad länssjukhus</name>
      <address>
        <city>Kristianstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matilda Friman-Mathiasson, MD</last_name>
      <email>Matilda.Friman-Mathiasson@skane.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Skaraborgs sjukhus Skövde</name>
      <address>
        <city>Skövde</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emelie Ottosson, MD</last_name>
      <phone>+46500478286</phone>
      <email>emelie.ottosson@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>BB Stockholm</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sofie Graner, MD PhD</last_name>
      <phone>+46706849239</phone>
      <email>Sofie.Graner@bbstockholm.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Danderyd</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophia Brismar Wendel, MD PhD</last_name>
      <phone>+46722024895</phone>
      <email>sophia.brismar-wendel@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital Solna</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Sandström, MD PhD</last_name>
      <email>anna.sandstrom@ki.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital- Huddinge</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karin Pettersson, MD PhD</last_name>
      <email>karin.ma.pettersson@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sebastian Brusell Gidlöf, MD PhD</last_name>
      <email>sebastian.brusell-gidlof@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Södertälje</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johanna Molin, MD</last_name>
      <email>johanna.molin@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sundsvall</name>
      <address>
        <city>Sundsvall</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie Vikström Bohlin, MD PhD</last_name>
      <email>marie.vikstrom.bolin@rvn.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Umeå University Hospital</name>
      <address>
        <city>Umeå</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna-Carin Wihlbäck, MD PhD</last_name>
      <email>anna-carin.wihlback@obgyn.umu.se</email>
    </contact>
    <contact_backup>
      <last_name>Magnus Domellöf, MD PhD</last_name>
      <email>magnus.domellof@umu.se</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna-Karin Wikström, MD PhD</last_name>
      <email>anna-karin.wikstrom@kbh.uu.se</email>
    </contact>
    <contact_backup>
      <last_name>Maria Jonsson, MD PhD</last_name>
      <email>maria.jonsson@kbh.uu.se</email>
    </contact_backup>
    <investigator>
      <last_name>Inger Sundström, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Västerås</name>
      <address>
        <city>Västerås</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Merit Kullinger, MD PhD</last_name>
      <phone>+4621173000</phone>
      <email>merit.kullinger@regionvastmanland.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ystad</name>
      <address>
        <city>Ystad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Charlotte A Nilsson, Midwife</last_name>
      <email>Marie-Charlotte.A.Nilsson@skane.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helena Fadl, MD PhD</last_name>
      <phone>+460727121258</phone>
      <email>helena.fadl@regionorebrolan.se</email>
    </contact>
    <contact_backup>
      <last_name>Hanna Östling, MD PhD</last_name>
      <phone>+46705248070</phone>
      <email>helena.fadl@regionorebrolan.se</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <state>Östergötland</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Blomberg, MD PhD</last_name>
      <phone>+4613288956</phone>
      <email>marie.blomberg@regionostergotland.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vrinnevisjukhuset</name>
      <address>
        <city>Norrköping</city>
        <state>Östergötland</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Hjertberg, MD</last_name>
      <email>Linda.Hjertberg@regionostergotland.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>June 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Ylva Carlsson</investigator_full_name>
    <investigator_title>MD, PhD, Senior Consultant</investigator_title>
  </responsible_party>
  <keyword>sars-cov2</keyword>
  <keyword>covid-19</keyword>
  <keyword>pregnancy</keyword>
  <keyword>neonatal</keyword>
  <keyword>long-term follow-up</keyword>
  <keyword>complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Outcome variables</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>2024</ipd_time_frame>
    <ipd_access_criteria>Ethical permission</ipd_access_criteria>
    <ipd_url>http://www.optionstudien.se</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

